0001209191-21-050681.txt : 20210810
0001209191-21-050681.hdr.sgml : 20210810
20210810183122
ACCESSION NUMBER: 0001209191-21-050681
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210806
FILED AS OF DATE: 20210810
DATE AS OF CHANGE: 20210810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gruskin Daniel
CENTRAL INDEX KEY: 0001863053
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38707
FILM NUMBER: 211161420
MAIL ADDRESS:
STREET 1: 65 HAYDEN AVENUE
STREET 2: 2ND FLOOR
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001664106
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 471514975
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 HAYDEN AVE
STREET 2: 2ND FLOOR
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-245-0399
MAIL ADDRESS:
STREET 1: 65 HAYDEN AVE
STREET 2: 2ND FLOOR
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-06
0
0001664106
LogicBio Therapeutics, Inc.
LOGC
0001863053
Gruskin Daniel
C/O LOGICBIO THERAPEUTICS, INC.
65 HAYDEN AVE, FLOOR 2
LEXINGTON
MA
02421
0
1
0
0
Chief Medical Officer
Common Stock
2021-08-06
4
M
0
4798
A
4798
D
Common Stock
2021-08-09
4
S
0
1467
4.35
D
3331
D
Restricted Stock Units
2021-08-06
4
M
0
4798
0.00
D
Common Stock
4798
0
D
Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock of LogicBio Therapeutics, Inc. (the "Company").
This sale was made automatically by the Company to cover tax withholding obligations in connection with the vesting and settlement of the RSUs reported in the row above.
These RSUs vested on August 6, 2021, subject to the terms and conditions of the award and the Company's 2018 Equity Incentive Plan.
/s/ Jonathan Quick, as Attorney-in-Fact
2021-08-10